康缘药业：关于实际控制人的一致行动人增持公司股份的公告

Core Viewpoint - Jiangsu Kangyuan Pharmaceutical Co., Ltd. announced that its actual controller, Mr. Xiao Wei, and his associates, Mr. Xiao Lihao and Ms. Zhao Shiwen, have increased their shareholding in the company, reflecting their confidence in the company's future development and long-term investment value [1] Summary by Relevant Categories Shareholding Increase - The associates of the actual controller acquired a total of 80,000 shares, which represents 0.0141% of the company's total share capital [1] - The total amount invested in this share purchase was 1,252,109 yuan, excluding transaction fees [1] - This increase in shareholding does not trigger the obligation to report changes in equity [1]